India and UK are planning to conduct a study on 'Ashwagandha' for promoting recovery from COVID-19 in a boost to the traditional Indian medicine system.
Green Fungus or Aspergillosis and COVID-19 Infection
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.
Green fungus or Aspergillosis is caused by a common mold, which exists both indoors and outdoors. Every day, people inhale Aspergillus spores, but it isn't harmful. However, it affects people who have a weak immune system. If the infection is left untreated, it can cause pneumonia.
‘Ashwagandha is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in Covid, which is a multi-system disease with no evidence of its effective treatment or management.’
Ashwagandha (Withania Somnifera), commonly known as 'Indian winter cherry', is a traditional Indian herb that boosts energy, reduces stress, and makes the immune system stronger. The successful completion of the trial can be a major breakthrough and give scientific validity to India's traditional medicinal system. While there have been several studies on Ashwagandha to understand its benefits in various ailments, this is the first time the Ministry has collaborated with a foreign institution to investigate its efficacy on Covid-19 patients.
AIIA director Dr Tanuja Manoj Nesari, who is also a co-investigator in the project along with Dr Rajgopalan, Coordinator - International Projects, said that the participants have been randomly selected. Dr Sanjay Kinra of LSHTM is the principal investigator of the study.
Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.
With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.
With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.
Advertisement
Cancer Research During COVID-19
Cancer clinical trial enrolment slightly exceeded than expected during the COVID-19 pandemic due to the circumstances of enrolling and treating patients on clinical trials.
Cancer clinical trial enrolment slightly exceeded than expected during the COVID-19 pandemic due to the circumstances of enrolling and treating patients on clinical trials.
Source-IANS
COVID Cases Top 197.2 Million
Globally, the COVID-19 caseload has topped 197.2 million, while the deaths have surged to more than 4.20 million and vaccinations soared to over 4.04 billion.
Globally, the COVID-19 caseload has topped 197.2 million, while the deaths have surged to more than 4.20 million and vaccinations soared to over 4.04 billion.
